Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL7215786 | 0.78 | MMP12 (0.42) | ALDH1A1LMNASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11791386 | 0.76 | CYP19A1 (0.50) | CYP19A1MAPTLMNASLC6A2SLC6A4 | |
| SCHEMBL13318272 | 0.74 | CA12 (0.45) | CYP19A1ALDH1A1MAPTLMNAKDM4E | |
| SCHEMBL11791397 | 0.72 | CYP19A1 (0.47) | CYP19A1ALDH1A1LMNASLC6A2SLC6A4 | |
| SCHEMBL5720902 | 0.71 | CYP19A1 (0.42) | CYP19A1ALDH1A1LMNASLC6A2KDM4E | |
| SCHEMBL19306154 | 0.71 | KDM4E (0.57) | ALDH1A1MAPTLMNAKDM4EMEN1 | |
| SCHEMBL170301 | 0.71 | SLC6A2 (0.55) | ALDH1A1LMNASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28172621 | 0.70 | ALDH1A1 (0.51) | ALDH1A1MAPTNPSR1LMNAKDM4E | |
| SCHEMBL28759435 | 0.70 | LMNA (0.53) | ALDH1A1MAPTNPSR1LMNAKDM4E | |
| Hydrochloric Acid SCHEMBL128794 | 0.69 | SLC6A2 (0.53) | ALDH1A1LMNASLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6617474-B2 | Reacting olefinically unsaturated compound with carbon monoxide and hydrogen in presence of polar phase comprising: a non-aqueous ionic liquid comprising quaternary ammonium and/or a quaternary phosphonium compound and catalyst; adding solvent | INSTITUT FRANCAIS DU PETROLE (FR) | 2003-09-09 | — | — | US | disclosed |
| US-20020099243-A1 | Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099243-A1 | Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent | NUDT1, PHOSPHO1, SRSF6 | CYP19A1 3198/4885ALDH1A1 2394/4885MAPT 3655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.